4.5 Article

Selective screening for atrial fibrillation using multivariable risk models

Journal

HEART
Volume 104, Issue 18, Pages 1492-1499

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/heartjnl-2017-312686

Keywords

-

Funding

  1. Life Sciences Discovery Fund of Washington State, Seattle, WA [5628758]
  2. National Heart, Lung and Blood Institute of the NIH, Bethesda, MD [RC2HL101759]

Ask authors/readers for more resources

Objective Atrial fibrillation can lead to stroke if untreated, and identifying those at higher risk is necessary for cost-effective screening for asymptomatic, paroxysmal atrial fibrillation. Age has been proposed to identify those at risk, but risk models may provide better discrimination. This study compares atrial fibrillation risk models with age for screening for atrial fibrillation. Methods Nine atrial fibrillation risk models were compared using the Atherosclerosis Risk in Communities study (11373 subjects, 60.0 +/- 5.7 years old). A new risk model (Screening for Asymptomatic Atrial Fibrillation Events-SAAFE) was created using data collected in the Monitoring Disparities in Chronic Conditions study (3790 subjects, 58.9 +/- 15.3 years old). The primary measure was the fraction of incident atrial fibrillation subjects who should receive treatment due to a high CHA(2)DS(2)-VASc score identified when screening a fixed number equivalent to the age criterion. Secondary measures were the C statistic and net benefit. Results Five risk models were significantly better than age. Age identified 71 (61%) of the subjects at risk for stroke who subsequently developed atrial fibrillation, while the best risk model identified 96 (82%). The newly developed SAAFE model identified 95 (81%), primarily based on age, congestive heart failure and coronary artery disease. Conclusions Use of a risk model increases identification of subjects at risk for atrial fibrillation. One of the best performing models (SAAFE) does not require an ECG for its application, so that it could be used instead of age as a screening criterion without adding to the cost.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available